Collegium Pharmaceutical is rated a Buy after a guidance cut and stock drop, with the market pricing in an overly pessimistic ...

Pharmaceutical & Biotech Stock Introductory Series, Part 2, Episode 5 / 12 Total]IntroductionCollegium Pharmaceutical (COLL) ...

Collegium Pharmaceutical (ISIN US19459J1043) became the subject of Oppenheimer coverage on September 23, 2026, when the brokerage assigned an Outperform rating and a USD 50.00 price target, according ...

At-home remedies include the use of hot and cold compresses, wearing a night guard while you sleep, eating soft foods and ...

Jaboticaba contains polyphenols and dietary fiber that researchers are studying for their effects on oxidative stress, gut ...

The IV team went through about 10 needles and tried several IV sites on both arms, attorney Randy Spivey wrote in a court ...

Research suggests ginger tea may help reduce period pain and bloating. A 2024 meta-analysis found that 500 to 2,000 mg of ginger powder daily for the first 3 days of menstruation reduced pain ...

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading biopharmaceutical company focused on improving the lives of people living with serious and often misunderstood conditions, today announced that ...

Cannabidiol (CBD) gummies are a popular choice for their convenience and ease of use. While current research on CBD for pain relief is limited, some studies and anecdotal evidence suggest it may help.

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...